Clinical Trial Update: Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study) [NA]

View source ↗

Summary

The ESPIRA study, which evaluated extracorporeal removal of specific IgE from plasma in allergic asthma patients, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Snippet

Sponsor: Fresenius Medical Care Deutschland GmbH | Conditions: Allergic Asthma | NA | Status: COMPLETED